Lemon Balm (Melissa officinalis L.) in Human Nutrition: The Importance of Preparation Type, Bioavailability, and Dose for Health Outcomes—A Critical Review

Background: Lemon balm (Melissa officinalis L.) products vary in composition and exposure, limiting transfer of health claims. Methods: This narrative review combined an initial collection, retrospectively dated late August–early October 2026, with documented Europe PMC searches on 10 and 12 November 2026. Five queries combined botanical terms with clinical, preparation, digestion, pharmacokinetic and safety terms, without a lower publication-date limit. They retrieved 3959 unique records, not an eligible-study count. Purposive selection prioritised identifiable preparations and interpretable exposure or health outcomes. The 121 sources include 19 primary oral single-botanical intervention reports, four combination-product reports, two secondary human analyses, other human evidence, and analytical, experimental, review and guidance sources. Sixteen full-text randomised reports supported 18 outcome-specific RoB 2 assessments; provisional GRADE-informed profiles addressed selected comparisons rather than the full evidence base. Evidence was synthesised by preparation, model and indication, with selected mean differences and 95% confidence intervals recalculated from adequate summary data. Results: Trials provide favourable, null or inconclusive product-specific outcomes, alongside some unfavourable alertness/task effects, but provisional certainty is low or very low because of bias concerns and imprecision; incomplete ascertainment of unpublished evidence adds uncertainty. Digestion studies do not establish systemic exposure, and matched-dose infusion–extract pharmacokinetic equivalence remains untested. Conclusions: Standardised interventions, exposure–response studies, independent replication and longer safety follow-up are required. Narrative selection, incomplete historical logs and possible publication bias limit completeness and general dosing recommendations.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2026-11-19
DOI
https://doi.org/10.3390/nu18223848
Primary Topic
Medicinal Plant Extracts Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lemon Balm (Melissa officinalis L.) in Human Nutrition: The Importance of Preparation Type, Bioavailability, and Dose for Health Outcomes—A Critical Review

Grzegorz Zaguła, Karolina Kogut, Łukasz Kogut, Julia Jastrzębska et al.
Nutrients
Medicinal Plant Extracts Effects
article

Lemon Balm (Melissa officinalis L.) in Human Nutrition: The Importance of Preparation Type, Bioavailability, and Dose for Health Outcomes—A Critical Review

Grzegorz Zaguła, Karolina Kogut, Łukasz Kogut, Julia Jastrzębska, Czesław Puchalski
article en

Abstract

Background: Lemon balm (Melissa officinalis L.) products vary in composition and exposure, limiting transfer of health claims. Methods: This narrative review combined an initial collection, retrospectively dated late August–early October 2026, with documented Europe PMC searches on 10 and 12 November 2026. Five queries combined botanical terms with clinical, preparation, digestion, pharmacokinetic and safety terms, without a lower publication-date limit. They retrieved 3959 unique records, not an eligible-study count. Purposive selection prioritised identifiable preparations and interpretable exposure or health outcomes. The 121 sources include 19 primary oral single-botanical intervention reports, four combination-product reports, two secondary human analyses, other human evidence, and analytical, experimental, review and guidance sources. Sixteen full-text randomised reports supported 18 outcome-specific RoB 2 assessments; provisional GRADE-informed profiles addressed selected comparisons rather than the full evidence base. Evidence was synthesised by preparation, model and indication, with selected mean differences and 95% confidence intervals recalculated from adequate summary data. Results: Trials provide favourable, null or inconclusive product-specific outcomes, alongside some unfavourable alertness/task effects, but provisional certainty is low or very low because of bias concerns and imprecision; incomplete ascertainment of unpublished evidence adds uncertainty. Digestion studies do not establish systemic exposure, and matched-dose infusion–extract pharmacokinetic equivalence remains untested. Conclusions: Standardised interventions, exposure–response studies, independent replication and longer safety follow-up are required. Narrative selection, incomplete historical logs and possible publication bias limit completeness and general dosing recommendations.

NutrientsVol. 18(22)
Rzeszów University of Technology (PL), University of Rzeszów (PL)
Medicinal Plant Extracts Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon